Katri Typpo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Katri Typpo has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Sharon Y. Irving
School of Nursing, University of Pennsylvania, Philadelphia, PA 19104, USA
2 shared publications - Vijay Srinivasan
The Children’s Hospital of Philadelphia, Philadelphia, PA
2 shared publications A.-M. Brown
Emory University, Division Of Critical Care, Atlanta, United States of America
1 shared publication- Akira Nishisaki
The Children’s Hospital of Philadelphia, Philadelphia
1 shared publication - Bryan R. Wilson
St. Luke’s University Health Network
1 shared publication - Carol Kelley
University of Arizona, College Of Medicine, Tucson, United States of America
1 shared publication
Latest Publications
- Open Access
- 4 March 2021
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 22 (Supplement) , 21-22
O037 / #606: NON-INVASIVE VENTILATION PRACTICE FOR PRIMARY RESPIRATORY MANAGEMENT IN THE PEDIATRIC INTENSIVE CARE UNITS: AN INTERNATIONAL STUDY
- 4 March 2021
- Published by Wolters Kluwer Health in Pediatric Critical Care Medicine
- Vol. 22 (Supplement) , 21-22
Open AccessO037 / #606: NON-INVASIVE VENTILATION PRACTICE FOR PRIMARY RESPIRATORY MANAGEMENT IN THE PEDIATRIC INTENSIVE CARE UNITS: AN INTERNATIONAL STUDY
- 1 January 2018
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 46 (1) , 190
413: TIMING OF NUTRITION INITIATION AND CLINICAL OUTCOMES IN CRITICALLY ILL CHILDREN WITH HYPERGLYCEMIA
- 1 January 2018
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 46 (1) , 190
413: TIMING OF NUTRITION INITIATION AND CLINICAL OUTCOMES IN CRITICALLY ILL CHILDREN WITH HYPERGLYCEMIA
- 18 July 2017
- Published by Tech Science Press in Congenital Heart Disease
- Vol. 12 (6) , 815-819
Inaccuracy of a continuous arterial pressure waveform monitor when used for congenital cardiac catheterization
To determine the accuracy of a continuous cardiac output monitor (FloTrac sensor) for measuring cardiac index in children with congenital heart disease undergoing cardiac catheterization. Cardiac index is a critical hemodynamic parameter measured during catheterizations in children with congenital heart disease. This has been challenging to measure accurately and many clinicians rely on predictive equations for calculating cardiac index. Prospective, nonrandomized trial. Tertiary care congenital heart center. Consecutive participants ≤18 years old undergoing clinically indicated cardiac catheterizations from September 2014 through August 2015. Oxygen consumption was measured using the Vmax Encore 229 monitor attached to the ventilator circuit. The FloTrac transducer with third generation software was connected to a pigtail catheter in the descending aorta and cardiac index was obtained. Cardiac index by the Fick equation using measured oxygen consumption was compared to cardiac index from the FloTrac sensor using paired t-test and Bland–Altman analysis. 39 participants (median age 5.1 years, 1.5-18.3, 64% female) were studied. Cardiac index by FloTrac was higher than cardiac index by Fick (6.4 ± 3.4 vs 3.7 ± 1.2 L/min/m2, P < .001). Bland–Altman analysis showed a consistent overestimation of cardiac index by FloTrac which worsened as cardiac index increased (mean bias 2.7 L/min/m2, 95% limits of agreement −4.2, 9.5). The results of this study show that the FloTrac sensor provides cardiac index measures which are not accurate enough to justify use in children with congenital heart disease undergoing catheterization. Further studies may allow for modifications of the algorithms to obtain more accurate cardiac index in this population.
- 18 July 2017
- Published by Tech Science Press in Congenital Heart Disease
- Vol. 12 (6) , 815-819
Inaccuracy of a continuous arterial pressure waveform monitor when used for congenital cardiac catheterization
To determine the accuracy of a continuous cardiac output monitor (FloTrac sensor) for measuring cardiac index in children with congenital heart disease undergoing cardiac catheterization. Cardiac index is a critical hemodynamic parameter measured during catheterizations in children with congenital heart disease. This has been challenging to measure accurately and many clinicians rely on predictive equations for calculating cardiac index. Prospective, nonrandomized trial. Tertiary care congenital heart center. Consecutive participants ≤18 years old undergoing clinically indicated cardiac catheterizations from September 2014 through August 2015. Oxygen consumption was measured using the Vmax Encore 229 monitor attached to the ventilator circuit. The FloTrac transducer with third generation software was connected to a pigtail catheter in the descending aorta and cardiac index was obtained. Cardiac index by the Fick equation using measured oxygen consumption was compared to cardiac index from the FloTrac sensor using paired t-test and Bland–Altman analysis. 39 participants (median age 5.1 years, 1.5-18.3, 64% female) were studied. Cardiac index by FloTrac was higher than cardiac index by Fick (6.4 ± 3.4 vs 3.7 ± 1.2 L/min/m2, P < .001). Bland–Altman analysis showed a consistent overestimation of cardiac index by FloTrac which worsened as cardiac index increased (mean bias 2.7 L/min/m2, 95% limits of agreement −4.2, 9.5). The results of this study show that the FloTrac sensor provides cardiac index measures which are not accurate enough to justify use in children with congenital heart disease undergoing catheterization. Further studies may allow for modifications of the algorithms to obtain more accurate cardiac index in this population.
- Open Access
- 13 October 2016
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 4, 108
Nutrition: A Primary Therapy in Pediatric Acute Respiratory Distress Syndrome
Appropriate nutrition is an essential component of intensive care management of children with Acute Respiratory Distress Syndrome (ARDS) and is linked to patient outcomes. One out of every two children in the PICU will develop malnutrition or have worsening of baseline malnutrition, and present with specific micronutrient deficiencies. Early and adequate enteral nutrition (EN) is associated with improved 60-day survival after pediatric critical illness and yet, despite early EN guidelines, critically ill children receive on average only 55% of goal calories by PICU day 10. Inadequate delivery of EN is due to perceived feeding intolerance, reluctance to enterally feed children with hemodynamic instability, and fluid restriction. Underlying each of these factors is large practice variation between providers and across institutions for initiation, advancement and maintenance of EN. Strategies to improve early initiation, advancement, and to maintain delivery of EN are needed to improve morbidity and mortality from pediatric ARDS. Both over and underfeeding prolongs duration of mechanical ventilation in children and worsens other organ function such that precise calorie goals are needed. The gut is thought to act as a ‘motor’ of organ dysfunction and emerging data regarding the role of intestinal barrier functions and the intestinal microbiome on organ dysfunction and outcomes of critical illness present exciting opportunities to improve patient outcomes. Nutrition should be considered a primary rather than supportive therapy for pediatric ARDS. Precise nutritional therapies, which are titrated and targeted to preservation of intestinal barrier function, prevention of intestinal dysbiosis, preservation of lean body mass, and blunting of the systemic inflammatory response, offer great potential for improving outcomes of pediatric ARDS. In this review we examine the current evidence regarding dose, route, and timing of nutrition, current recommendations for provision of nutrition to children with ARDS, and the current literature for immune modulating diets for pediatric ARDS. We will examine emerging data regarding the role of the intestinal microbiome in modulating the response to critical illness.
- 13 October 2016
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 4, 108
Open AccessNutrition: A Primary Therapy in Pediatric Acute Respiratory Distress Syndrome
Appropriate nutrition is an essential component of intensive care management of children with Acute Respiratory Distress Syndrome (ARDS) and is linked to patient outcomes. One out of every two children in the PICU will develop malnutrition or have worsening of baseline malnutrition, and present with specific micronutrient deficiencies. Early and adequate enteral nutrition (EN) is associated with improved 60-day survival after pediatric critical illness and yet, despite early EN guidelines, critically ill children receive on average only 55% of goal calories by PICU day 10. Inadequate delivery of EN is due to perceived feeding intolerance, reluctance to enterally feed children with hemodynamic instability, and fluid restriction. Underlying each of these factors is large practice variation between providers and across institutions for initiation, advancement and maintenance of EN. Strategies to improve early initiation, advancement, and to maintain delivery of EN are needed to improve morbidity and mortality from pediatric ARDS. Both over and underfeeding prolongs duration of mechanical ventilation in children and worsens other organ function such that precise calorie goals are needed. The gut is thought to act as a ‘motor’ of organ dysfunction and emerging data regarding the role of intestinal barrier functions and the intestinal microbiome on organ dysfunction and outcomes of critical illness present exciting opportunities to improve patient outcomes. Nutrition should be considered a primary rather than supportive therapy for pediatric ARDS. Precise nutritional therapies, which are titrated and targeted to preservation of intestinal barrier function, prevention of intestinal dysbiosis, preservation of lean body mass, and blunting of the systemic inflammatory response, offer great potential for improving outcomes of pediatric ARDS. In this review we examine the current evidence regarding dose, route, and timing of nutrition, current recommendations for provision of nutrition to children with ARDS, and the current literature for immune modulating diets for pediatric ARDS. We will examine emerging data regarding the role of the intestinal microbiome in modulating the response to critical illness.